IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers

Area of Science:

• Nephrology
• Mitochondrial Biology
• Molecular Pathology

Background:

• Mitochondrial injury is implicated in kidney disease pathogenesis.
• The role of mitochondrial injury in IgA nephropathy (IgAN) is not well understood.
• Investigating mitochondrial injury in IgAN is crucial for understanding disease mechanisms and outcomes.

Purpose of the Study:

• To examine the association between mitochondrial injury and IgA nephropathy (IgAN).
• To investigate the relationship between mitochondrial injury markers and treatment outcomes in IgAN patients.
• To explore the potential of urinary mitochondrial DNA (mtDNA) as a biomarker in IgAN.

Main Methods:

• Prospective enrollment of IgAN patients and healthy volunteers (HVs).
• Measurement of urinary mitochondrial DNA (mtDNA) copy numbers for COX3 and ND1 genes.
• Correlation analysis of urinary mtDNA levels with proteinuria and estimated glomerular filtration rate (eGFR).

Main Results:

• Elevated urinary mtDNA levels were observed in IgAN patients compared to HVs.
• Urinary ND1 levels were higher in the low proteinuria group than in the high proteinuria group.
• Changes in urinary ND1 and COX3 levels correlated with changes in proteinuria and eGFR post-treatment.

Conclusions:

• Mitochondrial injury is involved in IgAN pathogenesis, potentially in early glomerular inflammation.
• Urinary mtDNA levels may indicate disease severity and progression in IgAN.
• Urinary mtDNA levels show promise as biomarkers for monitoring treatment response in IgAN.